GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 117 filers reported holding GENERATION BIO CO in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,715 | +46.2% | 8,632 | +112.1% | 0.00% | 0.0% |
| Q2 2023 | $22,380 | +131547.1% | 4,069 | +4.1% | 0.00% | 0.0% |
| Q1 2023 | $17 | +30.8% | 3,910 | +18.6% | 0.00% | 0.0% |
| Q4 2022 | $13 | -100.0% | 3,298 | -46.6% | 0.00% | 0.0% |
| Q3 2022 | $33,000 | -52.9% | 6,178 | -42.4% | 0.00% | -50.0% |
| Q2 2022 | $70,000 | +775.0% | 10,735 | +853.4% | 0.00% | – |
| Q1 2022 | $8,000 | -78.9% | 1,126 | -79.0% | 0.00% | -100.0% |
| Q4 2021 | $38,000 | -66.4% | 5,358 | +18.9% | 0.00% | -66.7% |
| Q3 2021 | $113,000 | +50.7% | 4,507 | +60.7% | 0.00% | +50.0% |
| Q2 2021 | $75,000 | +47.1% | 2,804 | +57.4% | 0.00% | +100.0% |
| Q1 2021 | $51,000 | +15.9% | 1,781 | +13.6% | 0.00% | 0.0% |
| Q4 2020 | $44,000 | -38.9% | 1,568 | -33.1% | 0.00% | 0.0% |
| Q3 2020 | $72,000 | – | 2,345 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |